We observed that patients with metastatic (M) PCa showed significantly higher levels of both Glo1 (Figure 2a) and PD-L1 (Figure 2b) expression with respect to patients with non-metastatic (NM) PCa. The gene discussed is GLO1; the disease is posterior cortical atrophy.